glp-1 for autoimmune Emerging Data Show Potential Risk of Diseases With Use Microdosing GLP-1 for autoimmune conditions:

Furthermore, their production processes are scalable, although a complete physico-chemical characterisation has still to be carried out in order to standardise the described approaches

"Pancrelipase Therapy", StatPearls , Treasure Island (FL): StatPearls Publishing, PMID 30521237, retrieved 2026-06-17 25

But what youre finding even with GLP-1s is that if there is a psychological component to it, that its more emotional eating, stress, as opposed to in response to the sight or taste of food, its not going to be as effective, and youre more likely to go back to the same behaviors after going off of them

Ozempic users with type 2 diabetes saw more modest reductions, with losses ranging from 8 to 14 pounds over two years (Ozempic, n.d.)

This ensures that the nutrients actually reach your cells, where they can support your energy, immunity, and ageing process